Koroner Arter Hastalığı Yaygınlığı’nın RDW ile İlişkisi
Öz
Anahtar Kelimeler
AKS , RDW , GENSİNİ SKORU
References
- 1. Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015;28(2):283-93.
- 2. Makki N, Brennan TM, Girotra S. Acute coronary syndrome. J Intensive Care Med. 2015;30(4):186-200.
- 3. Hedayati T, Yadav N, Khanagavi J. Non-ST-Segment Acute Coronary Syndromes. Cardiol Clin. 2018;36(1):37-52.
- 4. Piironen M, Ukkola O, Huikuri H, Havulinna AS, Koukkunen H, Mustonen J, et al. Trends in long-term prognosis after acute coronary syndrome. Eur J Prev Cardiol. 2017;24(3):274-80.
- 5. Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemöller K, von Beckerath N, et al. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. Am J Med 2006;119(4):355.e 1-8
- 6. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991;9(1):71-4.
- 7. Kato H, Ishida J, Imagawa S, Saito T, Suzuki N, Matsuoka T,et al. Enhanced erythropoiesis mediated by activation of the reninangiotensi system via angiotensin II type 1a receptor. FASEB J 2005;19(14):2023-5.
- 8. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V.The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994;121(3):181-6.
- 9. Melchio R, Rinaldi G, Testa E, Giraudo A, Serraino C, Bracco C, et al.Red cell distribution width predicts mid-term prognosis in patients hospitalized with acute heart failure: the RDW in Acute Heart Failure (RE-AHF) study. Intern Emerg Med. 2019;14(2):239-47.
- 10. Dai DF, Hwang JJ, Lin JL, Lin JW, Hsu CN, Lin CM, et al. Joint effects of Nterminal pro-B-type-natriuretic peptide and Creactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease. Circ J 2008;72(8):1316-23.